FACE TO FACE: Davender Kumar Bhati, Co Founder & Director, Invigorate Biotechnologies

In an exclusive rapid-fire interview on the sidelines of Global Bio India 2024 in New Delhi, Rahul Koul, Chief Editor, BioVoice News spoke to Davender Kumar Bhati, Co-Founder & Director, Invigorate Biotechnologies. Mr Bhati shared insights on his company’s key R&D focus areas, startup ecosystem, government policies, India’s US$ 300 billion bioeconomy target and much more.

Key Questions

♦ Since your inception two years ago, how has been the journey so far? Please tell us more about your company.

♦ What are the key objectives behind your R&D and the product pipeline?

♦ How do you look at the growth of Indian biotechnology industry and startup ecosystem?

♦ What are your views on the policy and the broader US$ 300 billion bioeconomy by 2030?

♦ Down the line, where do you see the company after 5 years?

About Davender Kumar Bhati

With over 22+ years’ experience in manufacturing and vaccine industry, Devender Kumar Bhati is an expert on establishment and implementation of QMS in existing and upcoming manufacturing units. Before embarking on his entrepreneurial journey, he has worked with the BioBridge Healthcare Solutions and the Panacea Biotec.

Well versed with quality risk management, change management and deviations tools, Mr Bhati has led many technology and process development initiatives including scaling up for Recombinant Hepatitis B vaccine, Recombinant Anthrax vaccine, Polysaccharides (HIB and Pneumococcal), Conjugate vaccines (HIBTT and Pneumococcal CRM conjugate. He was also the Unit Head of vaccine manufacturing facility and has expertise in upstream processing.

Click here now to watch the full interview for detailed insights.